|
IDEV is leading the way in developing minimally invasive medical technologies to protect and preserve anatomical function.
IDEV is focused on products that are truly differentiated and deliver clear patient benefits.
IDEV is investing in research and development.
IDEV. Architects of Intervention.
|
| News | ||||||
|
The following list includes the most current news releases from IDEV. To view an article, click on the date. All press releases are saved as .pdf documents. Medical Device Bureau Grants Licence Amendment for SUPERA VERITAS® 6 French Stent Delivery System Journal of Endovascular Therapy Publishes Two-Year Data On SUPERA® Stent Used in the Superficial Femoral Artery IDEV Technologies Receives FDA Clearance for its SUPERA VERITAS® 6 French Stent Delivery IDEV Technologies Launches Lower Profile SUPERA VERITAS® Stent Delivery System IDEV Technologies Announces Completion of SUPERB Clinical Trial Enrollment
Long Lesion Study Demonstrates SUPERA® Stent Efficacy in SFA and Popliteal Arteries SUPERA VERITAS® Receives Regulatory Approval in Australia
April
14, 2011 February 8, 2011 January 26, 2011 Long-Term European Data Released for SUPERA® Stent from IDEV Technologies November 30, 2010 IDEV Technologies Announces First U.S. Procedure with SUPERA VERITAS™ Transhepatic Biliary System November 3, 2010 IDEV Technologies Announces FDA 510(k) Clearance for SUPERA VERITAS™ October 21, 2010 IDEV Technologies Launches New Products in Europe October 7, 2010 IDEV Technologies Completes $46 Million Preferred Stock Financing with Piper Jaffray and Additional Strategic Investor June 24, 2010 IDEV Technologies Enters into an Exclusive Distribution Agreement with TriReme Medical May 24, 2010 IDEV Technologies Names Veteran Healthcare Executive Dennis Donohoe, M.D. Chief Medical Officer May 18, 2010 IDEV Technologies Introduces SUPERA VERITAS™ Stent Delivery System in Europe November 17, 2009 IDEV Technologies Names Christopher M. Owens President, Chief Executive Officer August 24, 2009 IDEV Technologies Announces First Patient Enrolled in Multi-Center Clinical Trial of SUPERA Peripheral Stent July 9, 2009 IDEV Technologies names veteran medical device executive Rick Anderson chairman of the Board of Directors March 18, 2009 U.S. Food and Drug Administration Clears Way for Multi-Center Clinical Trial of IDEV Technologies SUPERA Peripheral Stent January 21, 2008 IDEV Technologies Inc. Receives 510(k) Clearance for New SUPERA Biliary Stent Delivery Catheter
|
|
SUPERA® is a different
class of stent. |
|
|
| Home | Company | Products | Patients | Clinical | Site Map | Legal Disclaimer | Privacy Policy | Contact Us | Copyright© 2011, IDEV Technologies Web services provided by eCreations |